FEZZA, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 20.635
AS - Asia 2.014
EU - Europa 1.713
SA - Sud America 298
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 24.705
Nazione #
US - Stati Uniti d'America 20.581
SG - Singapore 996
CN - Cina 423
RU - Federazione Russa 274
UA - Ucraina 258
BR - Brasile 253
DE - Germania 225
IT - Italia 221
HK - Hong Kong 202
IE - Irlanda 183
VN - Vietnam 150
FR - Francia 120
SE - Svezia 101
PL - Polonia 95
GB - Regno Unito 92
FI - Finlandia 61
KR - Corea 61
JP - Giappone 60
IN - India 29
CA - Canada 28
MX - Messico 21
AR - Argentina 19
BE - Belgio 16
ES - Italia 13
ZA - Sudafrica 13
BD - Bangladesh 12
CZ - Repubblica Ceca 12
EC - Ecuador 10
NL - Olanda 10
IQ - Iraq 8
TR - Turchia 8
EU - Europa 6
HU - Ungheria 6
ID - Indonesia 6
IL - Israele 6
KG - Kirghizistan 6
VE - Venezuela 6
AU - Australia 5
IR - Iran 5
TH - Thailandia 5
AT - Austria 4
GR - Grecia 4
JO - Giordania 4
PH - Filippine 4
RO - Romania 4
CL - Cile 3
MA - Marocco 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DZ - Algeria 2
JM - Giamaica 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SC - Seychelles 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 24.705
Città #
Woodbridge 5.872
Wilmington 5.458
Houston 4.721
Fairfield 673
Singapore 626
Ann Arbor 481
Chandler 370
Ashburn 328
Seattle 272
Jacksonville 247
Cambridge 223
San Jose 219
Hong Kong 196
Beijing 180
Dublin 179
Medford 145
Dearborn 121
Santa Clara 97
Los Angeles 82
Kraków 78
The Dalles 72
New York 69
Lawrence 66
Tokyo 50
Ho Chi Minh City 49
Hanoi 44
Rome 43
Moscow 39
Mülheim 39
Dallas 30
San Diego 30
Buffalo 29
Council Bluffs 29
Menlo Park 28
Munich 28
Lauterbourg 26
São Paulo 26
Milan 20
Chicago 19
Brussels 16
London 16
San Mateo 16
Boardman 15
Warsaw 15
Orem 13
Chennai 12
Verona 12
Brno 11
Zhengzhou 11
Columbus 10
Nuremberg 10
Atlanta 9
Johannesburg 9
Phoenix 9
Redondo Beach 9
Redwood City 9
Brooklyn 8
Frankfurt am Main 8
Hefei 8
Montreal 8
Seoul 8
Shanghai 8
Toronto 8
Curitiba 7
Kunming 7
Mexico City 7
Nanjing 7
Poplar 7
Saint Petersburg 7
San Francisco 7
Detroit 6
Falls Church 6
Fortaleza 6
Naples 6
Palo Alto 6
Rio de Janeiro 6
Berlin 5
Boston 5
Cagliari 5
Cangzhou 5
Da Nang 5
Denver 5
Guangzhou 5
Helsinki 5
North Bergen 5
University Park 5
Amman 4
Auburn Hills 4
Baghdad 4
Campinas 4
Dhaka 4
Guayaquil 4
Haiphong 4
Justice 4
Lappeenranta 4
Marília 4
Miskolc 4
Mountain View 4
Norwalk 4
Nürnberg 4
Totale 21.753
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 532
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 513
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 504
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 486
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 482
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 480
Endocannabinoids, related compounds and their metabolic routes 472
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 463
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 462
The anandamide membrane transporter and the therapeutic implications of its inhibition 462
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 460
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 455
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 455
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 454
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 452
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 448
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 442
Evidence for the intracellular accumulation of anandamide in adiposomes 438
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 438
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 437
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 435
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 435
Methods to assay anandamide hydrolysis and transport in synaptosomes. 434
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 433
New insights into endocannabinoid degradation and its therapeutic potential 432
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 432
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 432
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 431
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 428
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 428
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 423
Endocannabinoids and their involvement in the neurovascular system. 421
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 421
Endocannabinoid biochemistry: What do we know after 50 years? 421
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 419
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 419
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 418
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 414
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 412
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 411
Pitfalls and solutions in assaying anandamide transport in cells. 405
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 404
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 397
The endocannabinoid system in neurodegeneration. 397
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 394
null 393
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 387
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 386
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 381
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 366
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 365
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 248
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 218
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 185
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 182
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 159
The endocannabinoid hydrolase FAAH is an allosteric enzyme 158
Assay of NAPE-PLD Activity 152
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 150
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 125
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 122
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 115
Plant-Derived and Endogenous Cannabinoids in Epilepsy 108
Bisphenol A deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin B production 106
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 91
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 74
Radiometric Assay of NAPE-PLD Activity 73
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 73
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 65
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 64
Fatty acid amide hydrolase, anandamide, and neurological diseases 63
Endocannabinoids and platelets - Signalling pathways 60
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 49
Endocannabinoids and platelets - Differentiation 44
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 33
Totale 24.826
Categoria #
all - tutte 55.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 81 129 42
2021/2022665 22 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/20251.462 74 348 194 90 25 111 127 72 105 116 133 67
2025/20262.285 213 122 291 205 282 85 314 334 266 173 0 0
Totale 24.826